We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CSWYF market cap is 765.22M. The company's latest EPS is CNY 0.8740 and P/E is 1.06.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 2.57B | 2.71B | 2.66B | 3.22B | 3.95B |
| Operating Income | 533.07M | 526.48M | 285.77M | 643.61M | 835.77M |
| Net Income | 505.88M | 503.15M | 295.03M | 556.67M | 722.77M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 6.73B | 7.13B | 7.21B | 7.2B | 8.23B |
| Total Liabilities | 966.01M | 1.35B | 1.42B | 1.3B | 1.85B |
| Total Equity | 5.77B | 5.78B | 5.79B | 5.9B | 6.38B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 532.59M | 368M | 638.57M | 703.15M | 1.11B |
| Investing | 112.94M | 69.54M | -305.59M | 395.01M | -45.42M |
| Financing | -565.44M | -100.69M | -329.79M | -828.94M | -250.04M |
| Market Cap | 765.22M |
| Price to Earnings Ratio | 1.06 |
| Price to Sales Ratio | 0.19 |
| Price to Cash Ratio | 0.15 |
| Price to Book Ratio | 0.12 |
| Dividend Yield | - |
| Shares Outstanding | 827M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -14.32% |
| 52 Week High | 1.08 |
| 52 Week Low | 0.9253 |
| Spread (Intraday) | 100.49 (99.28%) |
| Company Name | China Shineway Pharmaceutical Group Limited (PK) |
| Address |
cricket square grand cayman KY1-1111 |
| Website | https://www.shineway.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
